MA52971A - Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle - Google Patents

Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle

Info

Publication number
MA52971A
MA52971A MA052971A MA52971A MA52971A MA 52971 A MA52971 A MA 52971A MA 052971 A MA052971 A MA 052971A MA 52971 A MA52971 A MA 52971A MA 52971 A MA52971 A MA 52971A
Authority
MA
Morocco
Prior art keywords
muscle
compositions
treatment
methods
fat infiltration
Prior art date
Application number
MA052971A
Other languages
English (en)
Inventor
Manu Chakravarthy
William Comb
Michael Hamill
Tony Tramontin
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of MA52971A publication Critical patent/MA52971A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA052971A 2018-06-20 2019-06-19 Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle MA52971A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862687737P 2018-06-20 2018-06-20

Publications (1)

Publication Number Publication Date
MA52971A true MA52971A (fr) 2021-04-28

Family

ID=67303508

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052971A MA52971A (fr) 2018-06-20 2019-06-19 Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle

Country Status (8)

Country Link
US (3) US10596136B2 (fr)
EP (1) EP3810123A1 (fr)
JP (1) JP2021527670A (fr)
CN (1) CN112839643A (fr)
AR (1) AR115585A1 (fr)
MA (1) MA52971A (fr)
TW (1) TW202015666A (fr)
WO (1) WO2019246225A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2018201024A1 (fr) 2017-04-28 2018-11-01 Axcella Health Inc. Compositions d'acides aminés et leur utilisation pour le traitement d'une lésion cérébrale traumatique
WO2019036471A1 (fr) 2017-08-14 2019-02-21 Axcella Health Inc. Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
EP3810123A1 (fr) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
BR112020025831A2 (pt) 2018-06-20 2021-03-23 Axcella Health Inc. métodos de fabricação de composições de aminoácidos
US20230044475A1 (en) * 2019-12-23 2023-02-09 Axcella Health Inc. Compositions and methods involving amino acids for the treatment of fat infiltrations in muscle
US11737999B2 (en) 2021-07-26 2023-08-29 Axcella Health Inc. Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19
KR20250028111A (ko) * 2023-08-21 2025-02-28 마이오펫 주식회사 반려동물용 근감소증의 예방 또는 치료용 약학적 조성물

Family Cites Families (322)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US693094A (en) 1900-08-13 1902-02-11 Hall Signal Co Signal and signaling-circuit.
US2457820A (en) 1945-12-27 1949-01-04 Merck & Co Inc Amino acid solution and process for preparing the same
US3012926A (en) 1957-10-17 1961-12-12 Arvin Ind Inc Method of making quilted padded articles
GB1034358A (en) 1963-05-01 1966-06-29 Chugai Pharmaceutical Co Ltd Body-protein-biosynthesis promoting composition
JPS5133B1 (fr) 1969-07-25 1976-01-05
US3832465A (en) 1971-12-09 1974-08-27 H Ghadimi Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
US3988466A (en) 1973-06-01 1976-10-26 Kyowa Hakko Kogyo Co., Ltd. Prevention of gastric lesions
US3950529A (en) 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
JPS52108031A (en) 1976-03-04 1977-09-10 Masahiro Takizawa Method of preparation of tooth paste
JPS5470158A (en) 1977-11-14 1979-06-05 Nhk Spring Co Ltd Cushion and making method thereof
JPS5535049A (en) 1978-09-04 1980-03-11 Otsuka Pharmaceut Factory Inc Amino acid transfusion for cancerous patient
DE2906034C2 (de) 1979-02-16 1985-03-28 Maggi AG, Kempttal Verfahren zur Gewinnung von L-Leucin, L-Phenylalanin, L-Tyrosin, L-Cystin und von Gemischen aus L-Leucin und L-Isoleucin
US4898879A (en) 1981-06-29 1990-02-06 Baxter International Inc. Nurtitional composition for management of hepatic failure
CA1184499A (fr) 1981-06-29 1985-03-26 David C. Madsen Compose nutritif pour le traitement de l'insuffisance hepatique
JPS58126767A (ja) 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
US5298493A (en) 1983-04-20 1994-03-29 Clintec Nutrition Co. Compound for use in dietetics, reanimation and therapeutics containing protein fractions based on three types of minipeptides
CH658165A5 (fr) 1984-01-04 1986-10-31 Nestle Sa Produit alimentaire efficace dans le traitement de la lepre.
US5034377A (en) 1984-11-19 1991-07-23 Montefiore Hospital Association Of Western Pennsylvania Aqueous nutrient compositions comprising oligopeptides
US4871550A (en) 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
FR2618331B1 (fr) 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
US5028622A (en) 1988-05-06 1991-07-02 Ajinomoto Company, Inc. Administration of amino acids as treatment for neurodegenerative disorders
US5576351A (en) 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
AU650293B2 (en) 1990-11-01 1994-06-16 Nestec S.A. High acid system nutritional formulations
US5106836A (en) 1991-02-22 1992-04-21 Clintec Nutrition Co. Enteral diet
US5977073A (en) 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
US5780039A (en) 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
US5229136A (en) 1992-05-21 1993-07-20 Clintec Nutrition Co. Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
US5276018A (en) 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
DE4229166A1 (de) 1992-09-01 1994-03-03 Deutsches Krebsforsch Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse
US5356873A (en) 1992-11-05 1994-10-18 Clintec Nutrition Co. Method for providing nutritional requirements to patients having a chronic inflammation reaction
US5348979A (en) 1992-12-23 1994-09-20 Iowa State University Research Foundation Inc. Method of promoting nitrogen retention in humans
CA2143420C (fr) 1992-12-23 1999-01-19 Phyllis J. B. Acosta Aliments medicinaux pour le soutien nutritionnel dans les cas de maladies metaboliques chez le nourrisson et le jeune enfant
US5571783A (en) 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
WO1995004529A1 (fr) 1993-08-10 1995-02-16 Musashi Pty. Ltd. Composition pour le traitement des effets resultant d'un abus d'alcool
US5438042B1 (en) 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
AU682894B2 (en) 1993-10-28 1997-10-23 Institut National De La Recherche Agronomique Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
US5378722A (en) 1993-12-03 1995-01-03 Clintec Nutrition Co. Nutritional compositions for management of nitrogen metabolism
US5723446A (en) 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
US5714472A (en) 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
GB9403935D0 (en) 1994-03-01 1994-04-20 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5719133A (en) 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
IT1275434B (it) 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
US5728678A (en) 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US6087398A (en) 1996-03-01 2000-07-11 South Alabama Medical Science Foundation Sickle cell anemia treatment
US5716926A (en) 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
US6096785A (en) 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
JPH1053521A (ja) 1996-08-12 1998-02-24 Kagaku Gijutsu Shinko Jigyodan 脳内グルタミン酸の活性抑制剤および活性増強剤
IT1289754B1 (it) 1996-12-16 1998-10-16 Professional Dietetics Srl Composizioni a base di aminoacidi
US6013273A (en) 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
US5817329A (en) 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
US5849335A (en) 1997-06-02 1998-12-15 Nestec S.A. Composition and method for providing glutamine
EP1123013A1 (fr) 1997-06-02 2001-08-16 Société des Produits Nestlé S.A. Produit et procede d'apport de glutamine
US6281244B1 (en) 1997-06-05 2001-08-28 Novartis Nutrition Ag Therapeutic use for glycine
ES2221095T3 (es) 1997-06-05 2004-12-16 Novartis Nutrition Ag Glicina para prevencion o tratamiento del rechazo de transplantes.
EP0891719A1 (fr) 1997-07-14 1999-01-20 N.V. Nutricia Composition dietique contenant de la methionine
IT1294227B1 (it) 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
TW473387B (en) 1997-09-30 2002-01-21 Chugai Pharmaceutical Co Ltd Pharmaceutical or food compositions for treating hepatic diseases or improving liver functions
US6288116B1 (en) 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US6203820B1 (en) 1998-05-28 2001-03-20 Brice E. Vickery Compositions and methods for enhancing protein anabolism and detoxification
US6103748A (en) 1998-06-19 2000-08-15 Bryan; Thomas B. Method of treating an autoimmune disorder
US6031000A (en) 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
JP2000072669A (ja) 1998-08-24 2000-03-07 Inst Of Physical & Chemical Res アミノ酸・糖組成物
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US20010041187A1 (en) 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
EP1004302A3 (fr) 1998-10-29 2003-06-04 Ajinomoto Co., Inc. Immunomodulateur
US6051236A (en) 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
US6143786A (en) 1999-02-02 2000-11-07 Novartis Nutrition Ag Oral arginine and insulin secretion
US6241996B1 (en) 1999-04-09 2001-06-05 Novartis Nutrition Ag Liquid soy nutritional products
HK1044100B (en) 1999-04-27 2005-07-22 Somalife Consulting Ltd. Supplement for restoring growth hormone levels
WO2001026642A2 (fr) 1999-10-08 2001-04-19 Joyce Corinne Bechthold Procedes et compositions pour le traitement de troubles de comportement neurologique
GB9929497D0 (en) 1999-12-14 2000-02-09 Vitaflo Limited Improved amino acid mixtures for the treatment and/or management of certain diseases
MXPA02007466A (es) 2000-02-01 2004-02-26 Muscletech Res And Dev Inc Suplemento alimenticio a base de acido alfa-lipoico para incrementar la masa muscular escas y la fuerza.
US6833350B2 (en) 2000-02-04 2004-12-21 Nestec S.A. Method for maintaining or improving the synthesis of mucins
US6521591B1 (en) 2000-02-10 2003-02-18 N.V. Nutricia Pharmaceutical composition for muscular anabolism
GB0009056D0 (en) 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
US7794744B2 (en) 2000-04-18 2010-09-14 Nestec S.A. Nutritional modules
US6391332B1 (en) 2000-04-20 2002-05-21 Baxter International, Inc. Therapeutic micronutrient composition for severe trauma, burns and critical illness
IT1320783B1 (it) 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari.
IT1320782B1 (it) 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
US20030187049A1 (en) 2000-07-04 2003-10-02 Dioguardi Francesco Saverio Compositions based on aminoacids, suitable for improving muscle performance
EP1372641A4 (fr) 2001-03-05 2004-08-25 Stephen P Ernest Formulation enterale
JPWO2002074302A1 (ja) 2001-03-15 2005-07-14 独立行政法人理化学研究所 肝機能障害改善用アミノ酸組成物
US20020193342A1 (en) 2001-05-09 2002-12-19 Hamman John P. Modifying undesirable tastes
ITTO20010580A1 (it) 2001-06-15 2002-12-15 Professional Dietetics Srl Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
US6864230B2 (en) 2001-07-31 2005-03-08 Novartis Nutrition Ag Glutamine rich dietary composition
EP1466602A4 (fr) 2001-12-25 2006-03-01 Ajinomoto Kk Inhibiteurs de fibrose des organes
US7622447B2 (en) 2002-01-25 2009-11-24 Diamedica Inc. Use of glutathione synthesis stimulating compounds in reducing insulin resistance
JP2003238401A (ja) 2002-02-20 2003-08-27 Ajinomoto Co Inc 疾患の治療、改善又は予防用医薬品及び飲食品
US7338675B2 (en) 2002-05-10 2008-03-04 Tsi Health Sciences, Inc. Fenugreek seed bio-active compositions and methods for extracting same
US20050176827A1 (en) 2002-05-10 2005-08-11 Lee Steve S. Compositions and methods for glycogen synthesis
ES2524000T3 (es) 2002-06-05 2014-12-03 Teva Czech Industries S.R.O. Reducción de la reticulación de la gelatina
JPWO2004019928A1 (ja) 2002-08-30 2005-12-15 味の素株式会社 肝疾患治療剤
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
US7037522B2 (en) 2002-09-27 2006-05-02 Western Holdings, L.L.C. Nocturnal muscle enhancing composition and method
JP2004123564A (ja) 2002-09-30 2004-04-22 Inst Of Physical & Chemical Res 中枢機能改善用アミノ酸組成物
JP2004182705A (ja) 2002-10-11 2004-07-02 Yasutoshi Koga ミトコンドリア機能異常に起因する疾患における臨床症状発現の予防・治療用組成物
US7547450B2 (en) 2002-10-24 2009-06-16 Nestec Ltd. Senior feline food
US8093292B2 (en) 2002-11-22 2012-01-10 Bionexus, Ltd. Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology
US7288570B2 (en) 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
US20040120983A1 (en) 2002-12-23 2004-06-24 Philip Connolly Nutritional supplement
JP4989836B2 (ja) 2002-12-26 2012-08-01 大塚製薬株式会社 経口栄養剤
EP1582207A4 (fr) 2002-12-26 2008-03-05 Ajinomoto Kk Inhibiteur de l'apparition et de l'evolution du cancer du foie
CA2516142A1 (fr) 2003-03-18 2004-09-30 Novartis Ag Compositions comprenant des acides gras et des acides amines
US20040213838A1 (en) 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
JP4528925B2 (ja) 2003-05-30 2010-08-25 独立行政法人理化学研究所 アミノ酸組成物及び補液
DK1638418T3 (da) 2003-06-23 2012-09-17 Nestec Sa Aminosyretilsætning til et sundt mikrobiota-økosystem
JP2005027524A (ja) 2003-07-08 2005-02-03 Ajinomoto Co Inc 経口アミノ酸組成物
WO2005017094A2 (fr) 2003-08-19 2005-02-24 Bioadvantex Pharma Inc. Compositions de n-acetyle comme therapie complementaire pour le traitement et la prevention des carences en cysteine/glutathion
ITTO20030789A1 (it) 2003-10-07 2005-04-08 Professional Dietetics Srl Composizione a base di amino acidi per il trattamento
ES2677868T3 (es) 2003-10-16 2018-08-07 Nestec S.A. Composición nutricional frente a los efectos secundarios de la quimioterapia o de la radioterapia
WO2005049006A1 (fr) 2003-11-21 2005-06-02 Ajinomoto Co., Inc. Remede contre les diabetes
DK1543735T3 (en) 2003-12-20 2015-11-02 Nestec Sa FOOD COMPOSITION FOR HEALTH CARE
JPWO2005072721A1 (ja) 2004-01-28 2007-09-06 味の素株式会社 局所脳血流低下に伴う神経系障害の予防または治療のための医薬組成物
WO2005082163A1 (fr) 2004-02-27 2005-09-09 Incorporated Administrative Agency National Agriculture And Food Research Organization Matière alimentaire enrichie en acide aminé libre et procédé servant à produire celle-ci
US20050233013A1 (en) 2004-03-02 2005-10-20 Lee Steve S Methods for enhancing the transport of glucose for balancing blood sugar levels
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
JP4815752B2 (ja) 2004-04-01 2011-11-16 味の素株式会社 アミノ酸含有飲食品
WO2005110124A1 (fr) 2004-04-15 2005-11-24 Abbott Laboratories Composition et procedes pour gestion nutritionnelle de patients a maladie hepatique
CN1582912A (zh) 2004-06-10 2005-02-23 武汉启瑞科技发展有限公司 L-鸟氨酸和 l-门冬氨酸组合物
US20060002913A1 (en) 2004-06-22 2006-01-05 Gehlsen Kurt R Use of histamine and related compounds to treat disorders affecting muscle function
RU2372900C2 (ru) 2004-07-14 2009-11-20 Адзиномото Ко., Инк. Ингибитор возникновения и развития рака печени для применения у пациентов-людей с циррозом печени, положительных по вирусу гепатита с
PL1771191T3 (pl) 2004-07-19 2014-08-29 Nutricia Nv Preparat do zastosowania asparaginianu i witaminy B12 lub biotyny do regulowania poziomu ciał ketonowych
EP1637163A1 (fr) 2004-09-21 2006-03-22 Andreas Kluge Indicateur pour la compliance thérapeutique
JP5177785B2 (ja) 2004-11-02 2013-04-10 味の素株式会社 周術期患者用薬剤
PT2319581E (pt) 2004-11-26 2015-06-30 Ucl Business Plc Composições compreendendo ornitina e fenilacetato ou fenilbutirato para tratamento de encefalopatia hepática
US20090048153A1 (en) 2004-12-03 2009-02-19 University Of Maryland, Baltimore Composition for treating sulfur mustard toxicity and methods of using same
JPWO2006061992A1 (ja) 2004-12-10 2008-06-05 味の素株式会社 肝疾患予防・治療用組成物
US20080114067A1 (en) 2005-01-31 2008-05-15 Takanobu Yamamoto Composition for Recovery From or Prevention of Central Nervous System Fatigue
CA2537647A1 (fr) 2005-03-01 2006-09-01 Six Star Formulations Ltd. Composition de complement alimentaire favorisant la croissance, la recuperation et le raffermissement des muscles
US20080193505A1 (en) 2005-03-15 2008-08-14 Nestec S.A. Nutritional Compositions For Modulating Vitamin C Bio-Availability
WO2006102451A2 (fr) 2005-03-21 2006-09-28 Abbott Laboratories Composition d'acides amines pour ameliorer la tolerance au glucose
US20100267831A1 (en) 2005-03-29 2010-10-21 Hisamine Kobayashi Amino Acid-Containing Composition for Preventing or Remedying Decrease in the Skeletal Muscle of Aged People
CN101175416A (zh) 2005-04-06 2008-05-07 诺瓦提斯公司 从营养方面改善葡萄糖控制和胰岛素作用的方法和组合物
US8993627B2 (en) 2005-04-21 2015-03-31 Sentient Lifesciences, Inc. N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
WO2006134135A2 (fr) 2005-06-14 2006-12-21 Nestec S.A. Methode nutritionnelle
JPWO2006137469A1 (ja) 2005-06-22 2009-01-22 味の素株式会社 代謝型グルタミン酸受容体活性化剤
US20100104548A1 (en) 2005-06-24 2010-04-29 Albert Einstein College Of Medicine Of Yeshiva University Modulation of amino acid metabolism in the hypothalamus
EP1920770A4 (fr) 2005-07-01 2010-09-29 Ajinomoto Kk Agent thérapeutique contre l'affection abdominale inflammatoire et inhibiteur de la production de tnf- alpha
JP5682990B2 (ja) 2005-08-04 2015-03-11 味の素株式会社 酸化型アルブミン低下剤
JP5067160B2 (ja) 2005-08-05 2012-11-07 味の素株式会社 肝癌発生・進展抑制剤
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
US20070053955A1 (en) 2005-08-26 2007-03-08 Nestec S.A. Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
EP1774973A1 (fr) 2005-10-12 2007-04-18 Nutricia N.V. Composition riche en leucine
BRPI0617824A2 (pt) 2005-10-28 2011-08-09 Nestec Sa métodos para o uso de aminoácidos de cadeia ramificada
US20080317886A1 (en) 2005-11-03 2008-12-25 Sparkman Dennis R Compositions for Preventing and Reducing Delayed Onset Muscle Soreness
US20070243211A1 (en) 2005-11-07 2007-10-18 Jaffe Russell M Compositions for regulating metabolic disorders and methods of use thereof
CN101316582A (zh) 2005-11-30 2008-12-03 雀巢技术公司 治疗肌肉损失的方法
ES2548432T3 (es) 2005-12-19 2015-10-16 Abbott Laboratories Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2
EP1971230A2 (fr) 2006-01-09 2008-09-24 Nestec S.A. Traitement de patients stressés
PL1983849T3 (pl) 2006-01-20 2013-09-30 Innova Food Ab Kompozycja spożywcza zawierająca aminokwasy
US20090087540A1 (en) 2006-01-31 2009-04-02 Nestec S.A. Nutritional composition for low birth weight infants
WO2007133642A1 (fr) 2006-05-11 2007-11-22 Garcia Ramon D Boisson pour sportif contenant des acides aminés et des glucides
JP5100033B2 (ja) 2006-05-16 2012-12-19 大塚製薬株式会社 消化管及び腎臓の萎縮抑制剤
US20070286909A1 (en) 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
US9192593B2 (en) 2006-08-30 2015-11-24 Ajinomoto Co., Inc. Amino-acid containing composition for inhibiting accumulation of fat
WO2008046870A1 (fr) 2006-10-19 2008-04-24 Nestec S.A. Alimentation par sonde à long terme pour patient cancéreux
US20080102137A1 (en) 2006-10-31 2008-05-01 Guffey Manning V R Composition and method for etiological treatment and prevention of diseases and/or complications associated with chronic glucose metabolism destabilization
GB0624879D0 (en) 2006-12-14 2007-01-24 Shs Int Ltd Treatment of pervasive development disorders
EP1932437A1 (fr) 2006-12-15 2008-06-18 Nestec S.A. Formule infantile
CN100518815C (zh) * 2007-02-15 2009-07-29 北京苏里曼医药科技有限公司 一种氨基酸组合物
US20080268038A1 (en) 2007-04-26 2008-10-30 Wolfe Robert R Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
CN101332209B (zh) 2007-06-25 2010-12-08 三菱制药(广州)有限公司 治疗肝性脑病的复方氨基酸注射液
US8455531B2 (en) 2007-09-18 2013-06-04 Thermolife International, Llc Amino acid compositions
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
KR100970664B1 (ko) 2007-10-11 2010-07-15 한화제약주식회사 L-오르니틴-l-아스파테이트를 함유한 겔제의 제조방법 및그 겔제
EP2057905A1 (fr) 2007-11-12 2009-05-13 TIMA Foundation Composition de modération des niveaux de triglycéride et de cholestérol
US20110077198A1 (en) 2007-11-26 2011-03-31 Michael John Tisdale Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition
CN101214050B (zh) 2007-12-28 2011-08-31 叶高山 一种具有提神、抗疲劳、醒酒功能的保健饮料
CA2709660C (fr) 2008-01-04 2018-06-05 Nestec S.A. Compositions comprenant des acides gras insatures et des composes liberant de l'oxyde nitrique et leur utilisation pour ameliorer des fonctions cognitives et apparentees
US7790688B2 (en) 2008-01-11 2010-09-07 Healthspan Solutions, Llc Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
US20090186098A1 (en) 2008-01-18 2009-07-23 Jose Briceno Sports drink composition
EP2095728B1 (fr) 2008-01-25 2011-09-07 Cesar Gallia s.r.l. Concentré d'acides aminés dans un gel aqueux et boisson supprimant la fatigue pouvant être obtenue en diluant ledit concentré dans de l'eau
US8716249B2 (en) 2008-01-31 2014-05-06 Energy Light Llc Compositions and methods for improving cardiovascular health
US20090203606A1 (en) 2008-02-05 2009-08-13 Wolfe Robert R Systems for and Methods of use of Therapeutic Nutrition for the Management of Age-Associated and Age-Specific Health Conditions of the Elderly
ES2483735T3 (es) 2008-02-07 2014-08-07 Nestec S.A. Composiciones y métodos para influir en la recuperación después de una actividad física intensa
EP2098124A1 (fr) 2008-03-03 2009-09-09 Nestec S.A. Gel de glucide
EP2098126A1 (fr) 2008-03-03 2009-09-09 Nestec S.A. Barre de glucide
CN102316730A (zh) 2008-05-09 2012-01-11 天雅瑞药业有限公司 用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释
CA2727088A1 (fr) 2008-06-04 2009-12-10 Phenolics, Llc Formulations a enrobage enterique de polyethyleneglycol et d'un ou plusieurs acides amines solubles pour ingestion orale et leur assimilation amelioree
US20100021573A1 (en) 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
WO2010033425A2 (fr) 2008-09-19 2010-03-25 Nestec S.A. Soutien nutritionnel pour prévenir ou modérer la paralysie de la moelle osseuse ou la neutropénie pendant un traitement anticancéreux
EP2165713B1 (fr) 2008-09-19 2012-11-14 Nestec S.A. Lactosérum améliorant la function du thymus
EP2351562A4 (fr) 2008-10-27 2012-09-05 Ajinomoto Kk Solution solide de valine, isoleucine et leucine et sa methode de production
US8362080B2 (en) 2008-12-18 2013-01-29 Baylor College Of Medicine Increasing glutathione levels for therapy
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
HUE034551T2 (en) 2009-01-12 2018-02-28 Biokier Inc Composition and method for treatment of diabetes
US20120178672A1 (en) 2009-03-18 2012-07-12 Wolfe Robert R Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
WO2010108542A1 (fr) 2009-03-25 2010-09-30 Nestec S.A. Base de saveur de renforcement du goût naturel et procédé pour sa préparation
CN106810464B (zh) 2009-04-03 2019-01-22 欧塞拉治疗有限公司 L-鸟氨酸苯乙酸盐及其制备方法
WO2010126353A1 (fr) 2009-04-27 2010-11-04 N.V. Nutricia Mélange de protéines à base de pois et utilisation de celui-ci dans une composition nutritionnelle liquide appropriée pour l'alimentation entérale
US8703719B1 (en) 2009-05-18 2014-04-22 Bio-Engineered Supplements And Nutrition, Inc. Method and composition for improved muscle performance
ES2517340T3 (es) 2009-06-08 2014-11-03 Ucl Business Plc Tratamiento de la hipertensión portal usando L-ornitina y fenilacetato
WO2010143939A1 (fr) 2009-06-09 2010-12-16 N.V. Nutricia Nutrition destinée à améliorer la résistance musculaire des personnes âgées
RU2012105901A (ru) 2009-07-20 2013-08-27 Нестек С.А. Способы снижения потери функционального состояния
WO2011030104A1 (fr) 2009-09-09 2011-03-17 Rajiv Jalan Acétate de phényle et/ou butyrate de phényle (non-ornithine) pour abaisser la pression sanguine dans la veine porte
CN101664384B (zh) 2009-09-18 2011-09-14 杭州市第六人民医院 N-乙酰半胱氨酸盐木糖醇注射液及其制备方法和应用
MX2012003459A (es) 2009-09-23 2012-05-22 Biokier Inc Composicion y metodo para el tratamiento de la diabetes.
WO2011044230A2 (fr) 2009-10-06 2011-04-14 Goldstein Glenn A N-acétylcystéine amide (nac amide) destiné au traitement de maladies et de conditions
WO2011043647A1 (fr) 2009-10-09 2011-04-14 N.V. Nutricia Composition d'acide aminé avec aptitude à la dispersion améliorée
EP2327316B1 (fr) 2009-11-29 2016-11-16 Premier Nutrition Corporation Procédé d'amélioration de la synthèse de protéines musculaires
PL2327315T3 (pl) 2009-11-29 2014-03-31 Nestec Sa Protokoły dawkowania dla zwiększenia syntezy białka u osób aktywnych
WO2011078654A1 (fr) 2009-12-24 2011-06-30 N.V. Nutricia Composition nutritionnelle hypocalorique riche en protéines destinée à la stimulation de la synthèse des protéines musculaires
JP2011132174A (ja) 2009-12-24 2011-07-07 Kirin Holdings Co Ltd 持久力向上剤
WO2011097273A1 (fr) 2010-02-02 2011-08-11 Martek Biosciences Corporation Méthodes et compositions permettant le traitement de la stéatose hépatique non alcoolique au moyen d'acide docosahexaénoïque et de n-acétyl-l-cystéine
EP2544555B1 (fr) 2010-03-12 2018-05-16 Nestec S.A. Compositions destinées à masquer la saveur de leucine et leurs procédés de fabrication
WO2011119023A1 (fr) 2010-03-26 2011-09-29 N.V. Nutricia Formule pour nourrisson à faible teneur en protéine dotée d'acides aminés essentiels accrus
JP2013529193A (ja) 2010-04-26 2013-07-18 ネステク ソシエテ アノニム 非経口栄養から経腸栄養へ離脱させるための栄養組成物及び方法
US8840950B2 (en) 2010-05-26 2014-09-23 Jacqueline M. Hibbert Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
WO2012005568A1 (fr) 2010-07-07 2012-01-12 N.V. Nutricia Composition nutritive de stimulation de synthèse de protéines musculaires
KR101213825B1 (ko) 2010-07-16 2012-12-18 서울대학교산학협력단 세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물
EP2596112A4 (fr) 2010-07-21 2015-01-21 Cumberland Pharmaceuticals Inc Compositions d'acétylcystéine et méthodes d'utilisation correspondantes
US20120020947A1 (en) 2010-07-22 2012-01-26 Northern Innovations And Formulations Corp. Compositions and methods for increasing lean muscle mass after exercise
CN101912394B (zh) 2010-08-06 2013-11-06 岳茂兴 一种用于治疗凝血障碍出血的药物组合物及其用途
EP2625162B1 (fr) 2010-10-06 2019-03-13 Ocera Therapeutics, Inc. Procédés de fabrication d'acétate de phényle de l-ornithine
EP2444083A1 (fr) 2010-10-21 2012-04-25 Nestec S.A. Cystéine et ingestion d'aliments
CN103338658A (zh) 2010-12-22 2013-10-02 雅培制药有限公司 含有β-羟基-β甲基丁酸钙和共轭亚油酸的营养型产品
EP2658535A1 (fr) 2010-12-27 2013-11-06 Abbott Laboratories Méthodes permettant de faciliter la récupération musculaire après une période d'inactivité faisant appel à du bêta-hydroxy-bêta-méthylbutyrate
WO2012097061A1 (fr) 2011-01-13 2012-07-19 Abbott Laboratories Compositions nutritionnelles et procédés pour améliorer le métabolisme protéique des muscles squelettiques
JP2014504605A (ja) 2011-01-25 2014-02-24 ネステク ソシエテ アノニム 動物の視覚系の劣化を治療、緩和又は予防するための方法及び組成物
RU2491062C2 (ru) 2011-03-16 2013-08-27 Общество С Ограниченной Ответственностью "Биотехнологии Пущино" Композиции протекторов острых и хронических печеночных энцелопатий и способ лечения острых и хронических печеночных энцелопатий
EP2685987B1 (fr) 2011-03-18 2019-04-24 Nestec S.A. Compositions et procédés utiles pour améliorer des maladies liées à l'âge
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
CN102327259A (zh) 2011-03-31 2012-01-25 姜国辉 具有显著化学性肝损伤保护功能的复合生物制剂
SG193926A1 (en) 2011-04-12 2013-11-29 Nestec Sa Nutritional compositions including branched chain fatty acids and methods of using same
JP2014512372A (ja) 2011-04-18 2014-05-22 ネステク ソシエテ アノニム α−HICA及びエイコサペンタエン酸を含有する栄養組成物
US20120270860A1 (en) 2011-04-19 2012-10-25 Gihyun Yoon Methods for treating or preventing alcohol-related disorders or craving-related disorders
JP2014513527A (ja) 2011-04-21 2014-06-05 ネステク ソシエテ アノニム パフォーマンス向上のための栄養組成物並びにその作製及び使用方法
US8828426B2 (en) 2011-06-07 2014-09-09 Zx Pharma, Llc Multiparticulate L-carnitine compositions and related methods
US20140135396A1 (en) 2011-07-05 2014-05-15 Beth Israel Deaconess Medical Center, Inc. Treatment of Acetaminophen-Induced Liver Damage by the Administration of Modulators of Nitric Oxide
JP6431670B2 (ja) 2011-08-08 2018-11-28 味の素株式会社 筋肉疲労の回復を促進するためのアミノ酸含有組成物
HK1199378A1 (en) 2011-08-19 2015-07-03 Musclepharm Corporation Compositions and methods for use in promoting lean body mass
EP2574333B1 (fr) 2011-09-27 2017-01-11 Friulchem SpA Comprimé effervescent de N-acétylcystéine et ses applications thérapeutiques
EP2580967A1 (fr) 2011-10-11 2013-04-17 Nestec S.A. Accélération de récupération musculaire après une atrophie du muscle induite par l'immobilisation
EP2583563A1 (fr) 2011-10-21 2013-04-24 Nestec S.A. Micelles de protéine de lactosérum contre l'amyotrophie et la sarcopénie
EP2583565A1 (fr) 2011-10-21 2013-04-24 Nestec S.A. Utilisation de micelles de protéines de lactosérum pour améliorer la dépense énergétique et la satiété
US9364463B2 (en) 2011-11-18 2016-06-14 Board Of Trustees Of The University Of Arkansas Use of amino acid supplementation for improved muscle recovery
BR112014011898A2 (pt) 2011-11-21 2017-05-16 Emmaus Medical Inc métodos e composições para o tratamento de diabetes e sintomas relacionados
WO2013081154A1 (fr) 2011-12-02 2013-06-06 味の素株式会社 Agent destiné à la réduction d'effets secondaires négatifs d'un inhibiteur de kinase
JP6192543B2 (ja) 2012-01-19 2017-09-06 昇一 城武 植物病原細菌用抗菌剤
US9198454B2 (en) 2012-03-08 2015-12-01 Nusirt Sciences, Inc. Compositions, methods, and kits for regulating energy metabolism
US20150119339A1 (en) 2012-06-11 2015-04-30 Abbott Laboratories Use of hmb to improve health outcomes for hospitalized patients
CN104582506B (zh) 2012-07-31 2016-10-19 雀巢产品技术援助有限公司 用于促进患有炎症性肠病(ibd)的患者的肌肉骨骼健康的营养组合物
CA2884717A1 (fr) 2012-09-14 2014-03-20 Nestec S.A. Nouvelles compositions aromatiques a arome et/ou duree de conservation d'arome ameliores
US8747921B2 (en) 2012-09-19 2014-06-10 Quality Ip Holdings, Inc. Methods for improving health in humans
US9198889B2 (en) 2012-09-19 2015-12-01 Quality IP Holdings, LLC Methods for treating post-traumatic stress disorder
US9066953B2 (en) 2012-09-20 2015-06-30 Quality IP Holdings, LLC Methods for increasing endurance and fat metabolism in humans
CN102961377A (zh) 2012-11-08 2013-03-13 湖北一半天制药有限公司 复方氨基酸注射液(20aa)的制备方法
ES2633769T3 (es) 2012-12-04 2017-09-25 Nestec S.A. Hexanoilglicina como biomarcador para la predisposición al aumento de peso y a la obesidad
MX369877B (es) 2013-02-04 2019-11-25 Seres Therapeutics Inc Composiciones y metodos.
MX361647B (es) 2013-03-11 2018-12-13 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.
SG11201507046UA (en) 2013-03-15 2015-10-29 Nusirt Sciences Inc Leucine and nicotinic acid reduces lipid levels
JP2016516419A (ja) 2013-03-26 2016-06-09 プレミア・ニュートリション・コーポレイション 同時トレーニングに続いて筋タンパク質合成を高めるための方法
EP2986156B2 (fr) 2013-04-15 2020-06-03 Société des Produits Nestlé S.A. Utilisation de la protéine de lactosérum en combinaison avec une stimulation musculaire électrique
US20160058726A1 (en) 2013-04-16 2016-03-03 The Children's Hospital Of Philadelphia Compositions and methods for the treatment of brain injury
US20140357576A1 (en) 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis
JP6677639B2 (ja) 2013-06-28 2020-04-08 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 運動パフォーマンスを高める組成物及び方法
WO2015015149A1 (fr) 2013-07-31 2015-02-05 Leeds Metropolitan University Complément alimentaire
SG11201602012RA (en) 2013-09-25 2016-04-28 Pronutria Inc Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
US20180125926A1 (en) 2013-09-25 2018-05-10 Axcella Health Inc. Compositions and Formulations and Methods of Production and Use Thereof
AU2014333977B2 (en) 2013-10-09 2019-12-19 Société des Produits Nestlé S.A. Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
EP3060231A1 (fr) * 2013-10-23 2016-08-31 The Whitehead Institute for Biomedical Research Modulation de mtorc1 par acides aminés et leurs utilisations
CA2939833A1 (fr) 2014-02-27 2015-09-03 Nusirt Sciences, Inc. Compositions et procedes permettant la reduction ou la prevention de steatose hepatique
GB2523578A (en) 2014-02-28 2015-09-02 Daniel Nelson A nutritional supplement
WO2015161448A1 (fr) 2014-04-22 2015-10-29 Wuhan Ll Science And Technology Development Co., Ltd. Compositions contenant de l'ornithine ou de l'aspartate et leurs utilisations
CN105092753B (zh) 2014-05-20 2016-09-07 中国科学院大连化学物理研究所 组合型胺类代谢标志物的应用及试剂盒
WO2016003263A1 (fr) 2014-07-01 2016-01-07 N.V. Nutricia Régime alimentaire à base d'acides aminés avec un goût amélioré
US10217645B2 (en) 2014-07-25 2019-02-26 Versum Materials Us, Llc Chemical mechanical polishing (CMP) of cobalt-containing substrate
US20160158305A1 (en) 2014-09-19 2016-06-09 Chip E. Thomson Additives and supplements
BR112017005762B1 (pt) 2014-10-14 2021-10-05 Société des Produits Nestlé S.A. Composição compreendendo uma fonte de proteína, e um antioxidante e seu uso
KR20230018526A (ko) 2014-11-24 2023-02-07 유씨엘 비즈니스 리미티드 암모니아-저감 치료를 이용한 간성상세포 활성화와 연관된 질병의 치료
US10272059B2 (en) 2014-12-04 2019-04-30 Professional Dietetics S.P.A. Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
US10894024B2 (en) 2014-12-08 2021-01-19 Synaptamine, Inc. Anti-RDS compounds and method of manufacture and administration thereof to induce dopamine homeostatis
EP3034074A1 (fr) 2014-12-18 2016-06-22 Universitat De València, Estudi General Composé pour le traitement de la dystrophie myotonique de type 1
US20170368026A1 (en) 2015-01-23 2017-12-28 Nestec S.A. Promotion of healing of intestinal mucosa using proline, serine and threonine
JP2018504406A (ja) 2015-01-23 2018-02-15 ネステク ソシエテ アノニム セリンを用いた炎症の治療又は予防
EP3247343A1 (fr) 2015-01-23 2017-11-29 Nestec S.A. Composition nutritionnelle utile dans le traitement de patients atteints d'une ibd
AU2016208457B2 (en) 2015-01-23 2022-03-24 Société des Produits Nestlé S.A. Method for determining the distinctive nutritional requirements of a patient
WO2016121829A1 (fr) 2015-01-27 2016-08-04 昇一 城武 Agent permettant le traitement ou la prévention de la dermatite utilisant des nanoparticules comme principe actif
CN107205962B (zh) 2015-02-13 2020-10-02 雀巢产品有限公司 手术诱导的恶病质的治疗或预防以及/或者骨髓来源的抑制性细胞和促炎性细胞因子的表达
US20180036270A1 (en) 2015-02-13 2018-02-08 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College A method of protecting against carbonyl stress induced ischemia-reperfusion injury in the diabetic brain via administration of n-acetylcysteine
FR3032883B1 (fr) 2015-02-24 2017-03-17 International Nutrition Res Company Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques
US20160302451A1 (en) 2015-04-16 2016-10-20 Michael Hudnall Medical Food for Patients with Chronic Liver Disease
HK1251149A1 (zh) 2015-04-20 2019-01-25 Ocera Therapeutics, Inc. L-鸟氨酸苯乙酸盐制剂
US10123985B2 (en) 2015-06-08 2018-11-13 Whitehead Institute For Biomedical Research Therapeutic strategies for treating mitochondrial disorders
CN107708446A (zh) 2015-06-22 2018-02-16 雀巢产品技术援助有限公司 用于增强动物体内神经形成的组合物和方法
MX380541B (es) 2015-06-30 2025-03-12 Soc Des Produits Nestle S A Star Composición adecuada para proteger microorganismos.
CA3185891A1 (fr) 2015-07-15 2017-01-19 Unigen, Inc. Compositions, methodes, et compositions a usage medical destinees a traiter le foie et a le maintenir en bonne sante
MX382576B (es) 2015-08-14 2025-03-13 Soc Des Produits Nestle S A Star Composiciones alimenticias semihúmedas que mantienen una textura blanda.
JP6990170B2 (ja) 2015-08-18 2022-01-12 オセラ セラピューティクス, インコーポレイテッド L-オルニチンをフェニルアセテートおよびフェニルブチレートのうちの少なくとも1つと組み合わせて用いる筋肉喪失の治療および予防
WO2017033272A1 (fr) 2015-08-25 2017-03-02 昇一 城武 Agent antimicrobien luttant contre les germes ayant un excellent effet de lutte contre les maladies des plantes
US20170079897A1 (en) 2015-09-20 2017-03-23 Matthew Brissette MINUS Composition for hair application and methods of hair care
JP6989495B2 (ja) 2015-09-25 2022-01-05 オセラ セラピューティクス, インコーポレイテッド L−オルニチンをフェニルアセテートおよびフェニルブチレートのうちの少なくとも1つと組み合わせて用いる神経細胞喪失の治療および予防
US20170196944A1 (en) * 2015-09-28 2017-07-13 Robert Portman Method to reduce muscle atrophy following orthopedic surgery
WO2017083758A1 (fr) 2015-11-13 2017-05-18 Ocera Therapeutics, Inc. Formulation de phénylacétate de l-ornithine
US11219611B2 (en) 2015-11-13 2022-01-11 Ocera Therapeutics, Inc. Formulations of L-ornithine phenylacetate
EP3851114B1 (fr) 2015-11-20 2024-10-09 Société des Produits Nestlé S.A. Composition comprenant des protéines lactosériques micellaires, de la vitamine d et du calcium pour l'utilisation dans la réduction du dépôt de gras dans les muscles squelettaux chez un individu âgé
CH713469B1 (de) 2015-12-21 2021-06-30 Nianjing Jianrong Bio Tech Co Ltd Zusammensetzung zum Behandeln von Motoneuron-Erkrankungen
US20190000866A1 (en) 2016-01-08 2019-01-03 Colonaryconcepts Llc Food based delivery of therapeutic agent for treatment of hepatic encephalopathy
GB201600990D0 (en) 2016-01-19 2016-03-02 Abbott Lab Pharmaceutical or nutritional combination
EP3454665A4 (fr) 2016-05-11 2020-02-19 Tsubo Solutions Pty Ltd Produit de confiserie
EP3463321A1 (fr) 2016-05-27 2019-04-10 Nestec S.A. Composition nutritionnelle pour le traitement ou la prévention de la diminution de la mobilité
PL238958B1 (pl) 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
US20180015122A1 (en) 2016-07-14 2018-01-18 Companion Supplements, LLC Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JOP20190147A1 (ar) * 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
CN106632605B (zh) 2016-12-22 2020-06-16 浙江海洋大学 利用金枪鱼下脚料制备的具有肝损伤修复作用的活性肽
SE540582C2 (en) 2016-12-22 2018-10-02 Scandibio Therapeutics Ab Substances for treatment of fatty liver-related conditions
EP3570826A4 (fr) 2017-01-19 2020-09-23 Otologic Pharmaceutics, Inc. Formulations de n-acétylcystéine et leurs utilisations
WO2018201024A1 (fr) 2017-04-28 2018-11-01 Axcella Health Inc. Compositions d'acides aminés et leur utilisation pour le traitement d'une lésion cérébrale traumatique
CN107242552A (zh) 2017-07-07 2017-10-13 上海东锦食品集团有限公司 具有缓解体力疲劳及增强免疫力功能的保健食品组合物
US20190046486A1 (en) 2017-08-14 2019-02-14 Axcella Health Inc. Compositions and methods for the treatment of neuronal injury
WO2019036471A1 (fr) 2017-08-14 2019-02-21 Axcella Health Inc. Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
CN108041501A (zh) 2017-12-22 2018-05-18 北京康比特体育科技股份有限公司 一种促进疲劳恢复的蛋白组合物及其制备方法
WO2019246221A1 (fr) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions et procédés pour le traitement de maladies et troubles hépatiques
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
EP3810123A1 (fr) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
BR112020025831A2 (pt) 2018-06-20 2021-03-23 Axcella Health Inc. métodos de fabricação de composições de aminoácidos
US11298332B2 (en) 2018-06-20 2022-04-12 Axcella Health Inc. Compositions for therapy and health containing amino acids with bitter taste
CN108524453A (zh) 2018-07-05 2018-09-14 扬子江药业集团广州海瑞药业有限公司 一种门冬氨酸鸟氨酸的药物组合物

Also Published As

Publication number Publication date
EP3810123A1 (fr) 2021-04-28
US20200016104A1 (en) 2020-01-16
US20210290573A1 (en) 2021-09-23
US10596136B2 (en) 2020-03-24
US10973793B2 (en) 2021-04-13
US11833127B2 (en) 2023-12-05
JP2021527670A (ja) 2021-10-14
AR115585A1 (es) 2021-02-03
WO2019246225A1 (fr) 2019-12-26
TW202015666A (zh) 2020-05-01
CN112839643A (zh) 2021-05-25
US20200281882A1 (en) 2020-09-10

Similar Documents

Publication Publication Date Title
EP3630072A4 (fr) Procédés et compositions pour le traitement d'une somnolence excessive
MA50849A (fr) Substances et procédés pour le traitement d'hémoglobinopathies
MA54609A (fr) Inhibiteurs aza-hétérobicycliques de mat2a et procédés d'utilisation pour le traitement du cancer
EP3612215A4 (fr) Compositions et procédés pour le traitement d'inflammation pulmonaire
MA54608A (fr) Inhibiteurs aza-hétérobicycliques de mat2a et procédés d'utilisation pour le traitement du cancer
MA71705A (fr) Substances et procédés pour le traitement d'hémoglobinopathies
MA51796A (fr) Procédés et compositions pour l'administration de protéines thérapeutiques
MA53873A (fr) Compositions et procédés pour le traitement de la presbytie
EP3781214A4 (fr) Compositions et procédés de traitement de l'amyotrophie spinale
MA45798A (fr) Compositions et procédés d'inhibition de masp-3 pour le traitement de maladies et troubles divers
EP3615016A4 (fr) Procédés et compositions pour le traitement d'apnée du sommeil
MA52961A (fr) Compositions et procédés pour la réduction ou le traitement d'une inflammation
EP3796920A4 (fr) Compositions d'arnt/pré-miarn et leur utilisation dans le traitement du cancer
EP4297871A4 (fr) Procédés et compositions pour le traitement de l'agitation
EP3877527A4 (fr) Compositions et procédés pour le criblage in vivo d'agents thérapeutiques
EP3876967A4 (fr) Microbiote thérapeutique pour le traitement et/ou la prévention d'une dysbiose
EP3639833A4 (fr) Agent pour la prévention ou le traitement de maladies liées à la graisse et/ou de l'inflammation
EP3634431A4 (fr) Compositions et méthodes thérapeutiques pour le traitement de l'hépatite b
EP3781143A4 (fr) Compositions et procédés pour le traitement d'une surcharge en fer
EP3448421A4 (fr) Procédés et compositions pour la prévention et le traitement d'adhérences chirurgicales
EP3810091A4 (fr) Méthodes et compositions pour le traitement de l'hypertension pulmonaire
EP3905942A4 (fr) Formulation pour utilisation dans le traitement de l'arthrose
EP3400008A4 (fr) Compositions thérapeutiques et méthodes pour le traitement de l'hépatite b
EP3801478A4 (fr) Méthodes et compositions pour la prévention ou le traitement de la calciphylaxie
EP3654961A4 (fr) Méthodes et compositions pour le traitement de la douleur à l'aide de la capsaïcine